Description
Mechanism of Action:
Clopidogrel is a P2Y12 platelet inhibitor that prevents platelets from clumping together, reducing the risk of clot formation that can lead to heart attacks or strokes.
Indications:
✔ Prevention of Heart Attacks and Strokes
✔ Acute Coronary Syndrome (ACS)
✔ Post-Stent Placement (Coronary Angioplasty)
✔ Peripheral Artery Disease (PAD)
Key Benefits:
✅ Reduces the risk of blood clots forming in arteries
✅ Used alongside aspirin in dual antiplatelet therapy (DAPT)
✅ Effective for long-term cardiovascular risk management
✅ Well-tolerated with a proven safety profile
Dosage & Administration:
- Clopidogrel 75 mg: Standard maintenance dose for cardiovascular risk prevention
- Route of Administration: Oral
- Food Intake: Can be taken with or without food
Precautions & Warnings:
- Use with caution in patients with bleeding disorders.
- Should not be used in patients with active bleeding conditions (e.g., peptic ulcers).
- May increase bleeding risk if combined with NSAIDs or anticoagulants.
Possible Side Effects:
- Bleeding tendencies (nosebleeds, gum bleeding, prolonged bleeding)
- Stomach upset or indigestion
- Bruising easily
- Rare allergic reactions
Storage & Packaging:
- Store below 30°C in a dry, dark place.
- Available in blister packs and bottle packaging as per regulatory and client needs.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP accredited facilities, adhering to EU-GMP standards for quality control.
Global Export & Supply:
Aetos Life Care exports Clopidogrel Bisulfate 75 mg to Latin America, Africa, Asia, Europe, and CIS countries, ensuring high-quality and cost-effective pharmaceutical solutions worldwide.
